Dermaheal EyeBag Solution (1.5 ml vial)

Dermaheal EyeBag Solution (1.5 ml vial)

Dermaheal

Aesthetic dermatology / mesotherapy solution
  • CE Marked mesotherapy product intended for professional aesthetic use in the EU.
  • Produced by Caregen — a biotechnology company specialising in biomimetic peptide therapies and aesthetic dermatology solutions.
Under-eye bag & puffiness treatment

Description

Dermaheal EyeBag Solution is a professional mesotherapy-grade peptide cocktail formulated to target under-eye bags, puffiness, fat herniation and skin laxity around the eye area. The solution combines biomimetic peptides that act on fat pads, microcirculation, lymphatic drainage and dermal tissue to reduce puffiness, smooth the skin, tighten the periorbital area and improve overall eye-zone appearance. It can be administered via mesotherapy injection, microneedling or other professional delivery systems, aiming to deliver visible reduction of eye bags and rejuvenation of the eyelid skin.

Bnefits

  • Reduces under-eye bags and puffiness by stimulating lipolysis and reducing fat pad volume under the eyes.
  • Improves microcirculation and lymphatic drainage in the periorbital area, reducing fluid retention and swelling.
  • Stimulates collagen, elastin and extracellular matrix production (via peptide action), improving skin firmness, elasticity and thickness.
  • Tightens and smooths the delicate under-eye skin, reducing fine lines and signs of fatigue.
  • Brightens and improves skin tone around the eyes, delivering a more rested, youthful and rejuvenated complexion.

Indications

  • Under-eye bags / under-eye fat herniation (lower eyelid bags).
  • Periorbital puffiness, swelling or fluid retention.
  • Thinning under-eye skin, loss of elasticity or skin laxity in the eye area.
  • Fine lines, wrinkles or crepiness around the eye area.
  • General tired, aged or fatigued appearance of under-eye area — wanting rejuvenation without surgery.

Composition

  • Tripeptide-41 (CG-Lipoxyn): peptide claimed to stimulate lipolysis and reduce subcutaneous fat deposits under the eyes.
  • Nonapeptide-18 (CG-Formade): peptide that supports collagen, elastin, hyaluronic acid and extracellular matrix production; anti-inflammatory and skin-tightening effects.
  • Oligopeptide-61 (CG-Cellsolin): peptide that helps improve skin elasticity, density and supports tissue structure.
  • Oligopeptide-73 (CG-EPG): peptide that stimulates microcirculation, lymphatic drainage and protects cells from oxidative stress or external damage; supports skin tightening and tone restoration.
  • Water (Aqua) and base solvents: as vehicle for peptide delivery.

Formulation

  • Sterile mesotherapy solution in 1.5 ml glass vials, designed for professional use.
  • Peptide-based bio-active cocktail targeting fat pads, circulation, lymphatic drainage, and tissue regeneration in the periorbital area.
  • Intended for injectable mesotherapy, microneedling, mesoroller or other professional delivery methods under sterile and controlled conditions.

Packaging

  • 1.5 ml sterile glass vial (single-use or single-session).
  • Typically sold in boxes containing 5 vials × 1.5 ml (total 7.5 ml) for a full treatment course.
  • Individual vials are labelled with batch, expiry and storage instructions; unopened shelf life ≈ 2 years from manufacture.

Usage

  • Use only under supervision of a trained and licensed aesthetic medicine professional.
  • Administer one vial (1.5 ml) per session for the under-eye / periorbital area, typically once a week.
  • Delivery via mesotherapy injection, mesoroller or microneedling device according to protocol.
  • Cleanse and disinfect skin before treatment; optionally use topical anaesthetic if needed.
  • After treatment, follow recommended aftercare: avoid sun exposure, rubbing, makeup or trauma to treated area; protect skin and support healing. (standard periorbital mesotherapy aftercare)

Contraindications

  • Pregnancy or breastfeeding.
  • Active infection, inflammation or open wounds in requested eye area.
  • Autoimmune diseases, uncontrolled systemic illnesses, or other contraindications judged by the treating professional (e.g. recent fillers, implants, etc.).
  • Known allergy or hypersensitivity to any of the peptide components or formulation excipients.
  • Use in individuals under 18 years of age is not recommended.
  • Injection should be avoided in areas with existing dermal fillers or shortly after filler procedures unless fully degraded — per some provider guidelines.

Adverse Effects

  • Possible transient redness, swelling, mild bruising or slight discomfort at injection site — typical for mesotherapy procedures.
  • Rare risk of allergic or irritant reaction to peptides or excipients, particularly in sensitive individuals.
  • If administered improperly — risk of uneven results, vascular or lymphatic complications, or local tissue irritation. (common mesotherapy caution)

Storage Conditions

  • Store unopened vials at room temperature, protected from direct sunlight and extreme heat/cold.
  • Shelf life ~2 years from manufacturing date when unopened.
  • Once opened, vial should be stored refrigerated (≈ 2–8 °C) and used within 5 days.
  • Keep out of reach of children and unauthorised persons. (standard for injectable products)

Duration

Typical course is 3\u20135 weekly sessions; maintenance sessions may be scheduled as needed (e.g. every few months) depending on patient response and practitioner protocol.

Onset

Some reduction in puffiness or under-eye bag appearance may be noticed after 1\u20132 sessions; more visible tightening, improved skin elasticity and reduction of eye bags often after completion of full course (3\u20135 sessions) and over subsequent weeks.

Browse more Aesthetic dermatology / mesotherapy solution

Top Treatments

Top Cities in the UK